explore -WSS

explore

author：hotspot 2025-09-10 08:44:21 - browse：37996

A syringe injects into a segment of DNA — biotech coverage from STAT — Adobe

Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday.

The results are “jaw-droppingly good, just shocking how good. It exceeded the wildest expectations of anybody who started this work,” said Larry Lustig, an otolaryngologist at Columbia University and an investigator on the study.

The new data come from a larger study by Regeneron Pharmaceuticals that will treat nearly two dozen children with a specific type of congenital hearing loss with gene therapy. The clinical trial is meant to measure safety and efficacy of DB-OTO, a gene therapy drug Regeneron is developing to treat children who have hearing loss due to changes in the otoferlin gene. Several teams are targeting this rare form of congenital deafness that affects 1% to 8% of deaf people globally, including a team with Akouos, an Eli Lilly subsidiary, which successfully treated an 11-year-old boy with a similar gene therapy. Lustig calls this the “lowest of the low-hanging fruit” for gene therapy deafness treatments.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： What do new weight loss drugs mean for bariatric surgery?

Wikipedia

WSS

Heat waves linked to early deliveries, preterm births in new study

Diversity in medical illustrations gets boost from Chidiebere Ibe

As pharma fights Medicare drug negotiation, hospitals, docs silent

NYU Langone launches private ChatGPT for its health care data

Psilocybin's anti

NYU Langone launches private ChatGPT for its health care data

entertainment

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Peter Hotez and the public health issue of online harassment

Appeals court upholds limits to abortion pill

How one medical school became remarkably diverse

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Alkermes shareholders re

Startling documents reveal new facets of Sacklers' opioid empire

What does generative AI mean for health care? We asked experts

FDA panel gives mixed vote on blood pressure devices

DIEP, the 'gold standard' of breast reconstruction, is under threat

Prosthetic arm enables patients to feel the objects they grip

focus

Health insurers say they are turning to AI to cut costs, improve care

FDA panel gives mixed vote on blood pressure devices

Akili, maker of video game for ADHD, to be acquired for 34 million

Health insurers say they are turning to AI to cut costs, improve care

Winners, losers from Medicare’s list of drugs subject to price talks

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

focus

hotspot

Wikipedia

focus